HT-003IBD
/ Hoth Therap
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
October 19, 2021
Hoth Therapeutics Extends Partnership Agreement with REPROCELL
(PRNewswire)
- "Hoth Therapeutics, Inc...has extended its partnership agreement with REPROCELL to assess the effect of the HT-003 therapeutic platform in inflammatory bowel disease (IBD). Fresh explants of ulcerative colitis and Crohn's disease tissues will be used to investigate the therapeutic potential of Hoth's HT-003 drugs. All testing will be performed at REPROCELL's Centre for Predictive Drug Discovery in Glasgow."
Licensing / partnership • Crohn's disease • Immunology • Inflammatory Bowel Disease • Ulcerative Colitis
March 11, 2021
Hoth Therapeutics Executes Agreement to Assess the Effect of HT-003 Therapeutic Platform on Ulcerative Colitis and Crohn's Disease
(PRNewswire)
- "Hoth Therapeutics, Inc...announced it has executed an agreement with REPROCELL Ltd...to assess the effect of the HT-003 therapeutic platform on tissue from ulcerative colitis and Crohn's disease patients. Fresh explants of ulcerative colitis and Crohn's disease tissues obtained from surgical resection will be used as the test systems to investigate the therapeutic potential of the HT-003 drugs via measurement of key biomarkers for these diseases."
Licensing / partnership • Crohn's disease • Immunology • Inflammatory Bowel Disease • Ulcerative Colitis
February 18, 2021
Hoth Therapeutics’ HT-003 Shows Anti-inflammatory Benefits, Hoth to Expand Drug Development to Include Treatment of Inflammatory Bowel Diseases (IBDs)
(PRNewswire)
- "Hoth Therapeutics, Inc...announced that it intends to expand the development of the HT-003...to pursue a new indication for the treatment of inflammatory bowel diseases (IBDs), including Crohn's disease and ulcerative colitis...Hoth plans to investigate the therapeutic potential of the HT-003 API using relevant ex vivo tissue models and other in vitro molecular studies...for the treatment of acne and psoriasis as a comprehensive therapeutic drug platform."
New indication • Preclinical • Crohn's disease • Inflammatory Bowel Disease • Psoriasis • Ulcerative Colitis
1 to 3
Of
3
Go to page
1